$27.53
-1.40-4.84%
最終更新: Oct 16, 4:00 PM
$27.53
-1.40-4.84%
Benzinga
Benzinga
Benzinga
月曜日, 10 19
Benzinga
© 2026 Benzinga | All Rights Reserved
Celldex Therapeutics (CLDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.06 | $-1.13 | $-1.00 | $-0.89 |
| Actual | $-0.94 | $-1.18 | $-1.22 | $-1.01 |
| Surprise | +11.3% | -4.42% | -22.0% | -13.5% |
| Revenue | ||||
| Estimate | $1.0M | $952800 | $1.5M | $1.3M |
| Actual | $22000 | $15000 | $100000 | $0 |
| Surprise | -97.9% | -98.4% | -93.1% | -100.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.01 | $-1.02 |
| Revenue | ||
| Consensus | $1.0M | $1.4M |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.94 | $-1.06 | 11.3 % |
| Q1 | May 7, 2026 | $-1.18 | $-1.13 | -4.42 % |
| Q4 | Feb 25, 2026 | $-1.22 | $-1.00 | -22.0 % |
| Q3 | Nov 10, 2025 | $-1.01 | $-0.89 | -13.5 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $22.00K | $1.04M | -97.9 % |
| Q1 | May 7, 2026 | $15.00K | $952.80K | -98.4 % |
| Q4 | Feb 25, 2026 | $100.00K | $1.45M | -93.1 % |
| Q3 | Nov 10, 2025 | $0 | $1.30M | -100.0 % |